Repligen Corp RGEN:NASDAQ

Last Price$276.84NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/01/21

Today's Change-9.66(3.37%)
Bid (Size)$269.68 (1)
Ask (Size)$287.00 (1)
Day Low / High$273.79 - 292.00
Volume592.1 K

Repligen to Acquire Chromatography Developer Avitide in $150 Million Cash-And-Stock Deal

8:26AM ET 9/16/2021 MT Newswires
Repligen (RGEN) said Thursday it has agreed to acquire privately held chromatography developer Avitide Inc. for about $150 million in cash and stock.

The purchase price includes $75 million in cash and $75 million in Repligen shares, in addition to performance-based earnouts over the next three years.

Repligen said Avitide is expected to contribute about $10 million of revenue in 2022, be accretive to adjusted earnings per share in 2023, strengthen its proteins business and move it into the affinity resin products market for gene therapy.

Repligen will fund the deal, which is expected to close in Q3, with cash on hand.

Price: 296.06, Change: -0.34, Percent Change: